MFC Hits 52-Week High: Time to Add the Stock for Better Returns?

Manulife Financial Corporation MFC hit a 52-week high of $37.46 on Jan 6. Shares closed at $37.40 after gaining 22% in the past year, outperforming the industry, the sector and the Zacks S&P 500 composite.

Manulife Financial has outperformed its peers, including Voya Financial, Inc. VOYA, Sun Life Financial Inc. SLF and Reinsurance Group of America, Incorporated RGA. Shares of VOYA and SLF have gained 2.3% and 8.8%, respectively, while RGA shares have lost 9% in the past year.

With a market capitalization of $62.88 billion, the average number of shares traded in the last three months was 1.9 million.

MFC Trading Above 50-Day and 200-Day Moving Averages

Shares of Manulife Financial are trading above the 50-day and 200-day simple moving averages (SMAs) of $34.69 and $31.89, respectively, indicating solid upward momentum. SMA is a widely used technical analysis tool to predict future price trends by analyzing historical price data.

Average Target Price for MFC Suggests Upside

Based on short-term price targets offered by 12 analysts, the Zacks average price target is $38.34 per share. The average suggests a potential 4.5% upside from the last closing price.

MFC’s Growth Projection Encourages

The Zacks Consensus Estimate for Manulife Financial’s 2026 earnings per share and revenues indicates an increase of 8.6% and 8.5%, respectively, from the corresponding 2025 estimates.

Optimist Analyst Sentiment on MFC

One of the two analysts covering the stock has raised estimates for 2026 over the past 30 days. Thus, the Zacks Consensus Estimate for 2026 earnings has moved up 2.5% in the past 30 days.

Manulife Financial’s Higher Return on Capital

Return on equity in the trailing 12 months was 16.1%, better than the industry average of 15.4%. This highlights the company’s efficiency in utilizing shareholders’ funds.

Key Points to Note for MFC

As its Asia business is reaping solid operational results, Manulife Financial targets to account for half of its core earnings by 2025 and play a crucial role in its long-term growth. Thus, the insurer is continually scaling up its business across Asia. We believe MFC is well-positioned to benefit from continued business growth momentum, higher expected earnings on insurance contracts and higher expected investment earnings, with notable growth from the largest in-force business, Hong Kong and an expanding distribution network.

Manulife Financial is expanding its Wealth and Asset Management business and has identified Europe (and the wider EMEA market) as a significant growth area. It is making long-term investments in this region. 

MFC has been accelerating growth in the highest-potential businesses. Its inorganic growth is impressive, as this life insurer prudently deploys capital in high-growth, less capital-intensive and higher-return businesses.

Banking on its sturdy capital position, MFC distributes wealth to shareholders through higher dividends and share buybacks. The company has increased its dividend at a seven-year CAGR of 10% and targets a 35-45% dividend payout over the medium term. 

MFC is strengthening its balance sheet and thus targets a leverage ratio of 25%. Notably, its free cash flow conversion has remained more than 100% over the last few quarters, reflecting its solid earnings.

What to Do With MFC Stock?

Manulife Financial is set to grow on solid Asia business, growing Wealth and Asset Management business, strong free cash flow conversion ratio and a solid capital position. A medium-term expense efficiency ratio target of less than 45%, banking on diligent expense management, should drive growth. 

Consistent wealth distribution makes it an attractive pick for yield-seeking investors, and favorable ROE also poises MFC for growth. MFC also has a VGM Score of B. Stocks with a favorable VGM Score are those with the most attractive value, best growth and most promising momentum compared with peers. 

Coupled with optimistic analyst sentiment and favorable growth estimates, the time appears right for potential investors to bet on this Zacks Rank #2 (Buy) insurer. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research